Skip to main content
. Author manuscript; available in PMC: 2014 May 10.
Published in final edited form as: Curr Pharm Des. 2012;18(9):1173–1185. doi: 10.2174/138161212799436368

Figure 6.

Figure 6

Shown in A and B are Ewald refinements of two MAP kinase complexes with non-ATP inhibitors that bind at the FRS-site. A.) The structure of the α isoform of JNK1 in complex with inhibitor 46A bound (PDB ID: 3O2M), which exhibits extensive interactions with a second copy of itself within the asymmetric unit of the crystal. B.) A promising structure of p38 MAPKα with inhibitor 3NE bound (PDB ID: 3NEW).